000 | 01990 a2200517 4500 | ||
---|---|---|---|
005 | 20250515223852.0 | ||
264 | 0 | _c20100617 | |
008 | 201006s 0 0 eng d | ||
022 | _a1538-7445 | ||
024 | 7 |
_a10.1158/0008-5472.CAN-09-1107 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeldmann, Georg | |
245 | 0 | 0 |
_aInhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. _h[electronic resource] |
260 |
_bCancer research _cJun 2010 |
||
300 |
_a4460-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xbiosynthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Cycle Proteins _xbiosynthesis |
650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCyclin-Dependent Kinase 5 _xantagonists & inhibitors |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aGene Knockdown Techniques |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPancreatic Neoplasms _xenzymology |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
650 | 0 | 4 |
_aral GTP-Binding Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aras Proteins _xantagonists & inhibitors |
700 | 1 | _aMishra, Anjali | |
700 | 1 | _aHong, Seung-Mo | |
700 | 1 | _aBisht, Savita | |
700 | 1 | _aStrock, Christopher J | |
700 | 1 | _aBall, Douglas W | |
700 | 1 | _aGoggins, Michael | |
700 | 1 | _aMaitra, Anirban | |
700 | 1 | _aNelkin, Barry D | |
773 | 0 |
_tCancer research _gvol. 70 _gno. 11 _gp. 4460-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-09-1107 _zAvailable from publisher's website |
999 |
_c19837828 _d19837828 |